GlassScriptPhysician profile
Rajinder P Singh
NPI 1184758799
$6,165.33
in general payments reported to CMS, 2019-2025
23 companies · $2,282 in 2025
The $2,282 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $611 · 2020: $241 · 2021: $780 · 2022: $1,041 · 2023: $657 · 2024: $554 · 2025: $2,282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,657 · Travel and Lodging: $836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,656.98 |
| Travel and Lodging | $836.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $3,099.14 | 2021-2025 | Carto 3, Octaray Mapping Catheter, Qdot Micro Catheter |
| Boston Scientific Corporation | $612.44 | 2021-2025 | Watchman Flx, Watchman Access System, Versacross Access Solution |
| Zoll Respicardia, INC. | $421.40 | 2021 | |
| Abbott Laboratories | $364.47 | 2021-2025 | Aveir, Assurity, Cardiomems |
| Biotronik INC. | $302.42 | 2023-2024 | Acticor 7 Vr-T Dx |
| Medtronic, INC. | $223.79 | 2021-2025 | Micra, Linq II |
| E.R. Squibb & Sons, L.L.C. | $185.04 | 2019 | |
| Novartis Pharmaceuticals Corporation | $139.19 | 2019 | |
| Medtronic Vascular, INC. | $135.14 | 2019-2020 | |
| Cardiva Medical, INC. | $102.00 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Amgen INC. | $88.29 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $81.61 | 2019-2025 | Lifevest |
| Cvrx, INC. | $74.98 | 2024 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $67.56 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $50.64 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $40.58 | 2019-2020 | |
| Amarin Pharma, INC. | $39.41 | 2019-2020 | |
| Pfizer INC. | $37.46 | 2019-2020 | |
| Philips North America LLC | $36.26 | 2023 | |
| Kestra Medical Technology Services, INC. | $17.84 | 2024 | Assure Wcd |
| Ironwood Pharmaceuticals, INC | $16.45 | 2020 | |
| Bardy Diagnostics, INC. | $15.00 | 2020 | |
| Cook Medical LLC | $14.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajinder Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.